Search results with tag "Reversible posterior"
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euPosterior Reversible Encephalopathy Syndrome (PRES) There have been reports of Posterior Reversible Encephalopathy Syndrome (PRES) in patients receiving Zejula (see section 4.8). PRES is a rare, reversible, neurological disorder which can present with rapidly evolving symptoms including seizures, headache, altered mental status, visual
著しい臥位高血圧，血圧変動が posterior reversible …
www.neurology-jp.orgPosterior reversible encephalopathy syndrome（PRES）は， 1966 年にHinchey ら1）により報告された疾患概念であり，頭 痛，意識障害，精神症状，痙攣，視野障害を主な臨床症候と する可逆性脳症で，悪性高血圧や子癇，免疫抑制剤などの使用
Prescribing Information | VELCADE® (bortezomib)
www.velcade.comPosterior Reversible Encephalopathy Syndrome: Consider MRI imaging for onset of visual or neurological symptoms; discontinue VELCADE if suspected. (5.5) Gastrointestinal Toxicity: Nausea, diarrhea, constipation, and vomiting may require use of antiemetic and antidiarrheal medications or fluid replacement. (5.6)
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.pi.amgen.com• Posterior Reversible Encephalopathy Syndrome (PRES): Consider neuro-radiological imaging (MRI) for onset of visual or neurological symptoms; discontinue Kyprolis if suspected. (5.14) • Progressive Multifocal Leukoencephalopathy: Consider PML if new or worsening neurologic manifestations. Discontinue Kyprolis in patients who develop PML.
Page 1 of 4 BEVACIZUMAB Bevacizumab in …
www.londoncanceralliance.nhs.ukThere have been rare reports of Bevacizumab-treated patients developing signs and symptoms that are consistent with Reversible Posterior Leukoencephalopathy Syndrome (RPLS), a rare neurologic disorder, which can present